Sino-Argi Leading Biosciences (603970) - Total Assets
Based on the latest financial reports, Sino-Argi Leading Biosciences (603970) holds total assets worth CN¥6.57 Billion CNY (≈ $960.83 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Sino-Argi Leading Biosciences cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Sino-Argi Leading Biosciences - Total Assets Trend (2012–2025)
This chart illustrates how Sino-Argi Leading Biosciences's total assets have evolved over time, based on quarterly financial data. Check Sino-Argi Leading Biosciences (603970) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Sino-Argi Leading Biosciences - Asset Composition Analysis
Current Asset Composition (December 2025)
Sino-Argi Leading Biosciences's total assets of CN¥6.57 Billion consist of 94.6% current assets and 5.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 5.1% |
| Accounts Receivable | CN¥1.45 Billion | 29.6% |
| Inventory | CN¥1.47 Billion | 29.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥3.08 Million | 0.1% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Sino-Argi Leading Biosciences's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Sino-Argi Leading Biosciences stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sino-Argi Leading Biosciences's current assets represent 94.6% of total assets in 2025, a decrease from 98.1% in 2012.
- Cash Position: Cash and equivalents constituted 5.1% of total assets in 2025, down from 6.1% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 29.9% of total assets.
Sino-Argi Leading Biosciences Competitors by Total Assets
Key competitors of Sino-Argi Leading Biosciences based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Yunnan Yuntianhua Co Ltd
SHG:600096
|
China | CN¥52.79 Billion |
|
Chengdu Wintrue Holding Co Ltd
SHE:002539
|
China | CN¥27.76 Billion |
|
Nanjing Red Sun Co Ltd
SHE:000525
|
China | CN¥6.84 Billion |
|
Nufarm Ltd
AU:NUF
|
Australia | AU$4.80 Billion |
|
Fanli Digital Technology Co Ltd
SHG:600228
|
China | CN¥575.15 Million |
|
Anhui Liuguo Chemical Co Ltd
SHG:600470
|
China | CN¥8.53 Billion |
|
Jiangsu Fengshan Group Co Ltd
SHG:603810
|
China | CN¥2.74 Billion |
|
Jiangsu Lanfeng Bio-chemical Co Ltd
SHE:002513
|
China | CN¥4.06 Billion |
Sino-Argi Leading Biosciences - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.33 | 1.28 | 1.27 |
| Quick Ratio | 0.79 | 0.79 | 0.79 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.54 Billion | CN¥1.51 Billion | CN¥1.06 Billion |
Sino-Argi Leading Biosciences - Advanced Valuation Insights
This section examines the relationship between Sino-Argi Leading Biosciences's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.16 |
| Latest Market Cap to Assets Ratio | 0.08 |
| Asset Growth Rate (YoY) | -12.3% |
| Total Assets | CN¥4.91 Billion |
| Market Capitalization | $403.57 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sino-Argi Leading Biosciences's assets below their book value (0.08x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Sino-Argi Leading Biosciences's assets decreased by 12.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sino-Argi Leading Biosciences (2012–2025)
The table below shows the annual total assets of Sino-Argi Leading Biosciences from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.91 Billion ≈ $718.70 Million |
-12.33% |
| 2024-12-31 | CN¥5.60 Billion ≈ $819.79 Million |
-6.76% |
| 2023-12-31 | CN¥6.01 Billion ≈ $879.19 Million |
-3.78% |
| 2022-12-31 | CN¥6.24 Billion ≈ $913.70 Million |
+31.68% |
| 2021-12-31 | CN¥4.74 Billion ≈ $693.86 Million |
+17.84% |
| 2020-12-31 | CN¥4.02 Billion ≈ $588.84 Million |
+46.89% |
| 2019-12-31 | CN¥2.74 Billion ≈ $400.87 Million |
+5.98% |
| 2018-12-31 | CN¥2.58 Billion ≈ $378.25 Million |
-7.12% |
| 2017-12-31 | CN¥2.78 Billion ≈ $407.23 Million |
+7.80% |
| 2016-12-31 | CN¥2.58 Billion ≈ $377.75 Million |
+2.60% |
| 2015-12-31 | CN¥2.52 Billion ≈ $368.18 Million |
+28.42% |
| 2014-12-31 | CN¥1.96 Billion ≈ $286.69 Million |
+18.43% |
| 2013-12-31 | CN¥1.65 Billion ≈ $242.07 Million |
+34.16% |
| 2012-12-31 | CN¥1.23 Billion ≈ $180.44 Million |
-- |
About Sino-Argi Leading Biosciences
Sino-Agri Leading Biosciences Co.,Ltd engages in pesticide distribution in China and internationally. The company sells technical materials, formulations, and related products. It also provides plant protection technology services; and crop health solutions, including technical guidance, application demonstration, and processing and packaging of plant protection products. In addition, the company… Read more